Mid career · publishing since 2006Rising activity
Acute Lymphoblastic Leukemia researchAcute Myeloid Leukemia ResearchLymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchProtein Degradation and Inhibitors
Publications
140
Citations
8,016
Est. group size
~26
Recurring co-author estimate
Active years
21
Publishing since 2006
In context
Among 4,491 mid career Medicine PIs within our index
Citations: 8,016p25 240 · p75 1,552 · cohort median 614
Publications / year (recent): 20.4p25 1.8 · p75 7.2 · cohort median 3.4
Typically publishes in teams of ~12 · 0% small-team papers (≤3 authors) · across 9 venues
Publication cadence
Publications per year over the last 10 years — averaging 20.4/year recently
Collaborators per year
Distinct co-authors at University of Michigan each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.
Recent publications
- The nascent transcriptome delineates the regulatory landscape in human health and disease
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Supplementary Table S4 from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023
- Supplementary Methods, Figure Legends, Table Legends from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023
- Supplementary Table S1 - S3 from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023
- Supplementary Figure S1 from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023
- Supplementary Figure S5 from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023
- Supplementary Figure S4 from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023
- Supplementary Figure S3 from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023
- Supplementary Figure S2 from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023
- Supplementary Table S1 - S3 from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023
- Supplementary Figure S5 from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023
- Supplementary Figure S2 from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023
- Supplementary Figure S4 from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023
- Supplementary Figure S1 from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023
- Supplementary Figure S3 from Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma
2023
Publishes in
- Blood×11
- bioRxiv (Cold Spring Harbor Laboratory)×8
- Nature×4
- Blood Cancer Discovery×4
- Figshare×4
Similar researchers
By research-topic overlap
- Travis Saari
Medicine · University of Michigan
- Y. Li
Medicine · Purdue University West Lafayette
- Nyla A. Heerema
Medicine · The Ohio State University
- Megan Fleming
Medicine · The Ohio State University
- Adam DuVall
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile